The efficacy, safety and ethics of the use of testosterone-suppressing agents in the management of sex offending
| dc.contributor.author | Mashru, Asha | |
| dc.date.accessioned | 2017-09-06T12:39:43Z | |
| dc.date.available | 2017-09-06T12:39:43Z | |
| dc.date.issued | 2016 | |
| dc.identifier.citation | Khan, O. & Mashru, A. (2016). The efficacy, safety and ethics of the use of testosterone-suppressing agents in the management of sex offending. Current Opinion in Endocrinology, Diabetes and Obesity, 23 (3), pp.271-278. | |
| dc.identifier.other | 10.1097/MED.0000000000000257 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12904/5124 | |
| dc.description | © 2016 Wolters Kluwer Health, Inc. All rights reserved. | |
| dc.description.abstract | PURPOSE OF REVIEW: The use of endocrine medications to reduce sexual offending recidivism is established and may involve clinicians from diverse specialities. The present review aims to outline relevant background information and note a Medical Ethics framework upon which to facilitate decision-making. | |
| dc.description.abstract | RECENT FINDINGS: There have been several systematic reviews in recent years. A number of problems with research in the area of the medical treatment of sex offenders have been highlighted. There remains scope for improvement in the research to answer a number of relevant clinical issues. Nonetheless, some very useful indicators of relevance to clinical practice have emerged. | |
| dc.description.abstract | SUMMARY: The use of medication to manage the risk of sex offending in males is appropriate under the right circumstances. These include, for example, hypersexuality with sexual deviance and psychological-treatment interfering sexual preoccupation. | |
| dc.description.uri | http://journals.lww.com/co-endocrinology/Abstract/2016/06000/The_efficacy,_safety_and_ethics_of_the_use_of.10.aspx | |
| dc.format | Full text uploaded | |
| dc.subject | Drug therapy | |
| dc.subject | Criminals | |
| dc.subject | Sex offenses | |
| dc.title | The efficacy, safety and ethics of the use of testosterone-suppressing agents in the management of sex offending | |
| dc.type | Article | |
| refterms.dateFOA | 2021-06-10T14:44:06Z | |
| html.description.abstract | PURPOSE OF REVIEW: The use of endocrine medications to reduce sexual offending recidivism is established and may involve clinicians from diverse specialities. The present review aims to outline relevant background information and note a Medical Ethics framework upon which to facilitate decision-making. | |
| html.description.abstract | RECENT FINDINGS: There have been several systematic reviews in recent years. A number of problems with research in the area of the medical treatment of sex offenders have been highlighted. There remains scope for improvement in the research to answer a number of relevant clinical issues. Nonetheless, some very useful indicators of relevance to clinical practice have emerged. | |
| html.description.abstract | SUMMARY: The use of medication to manage the risk of sex offending in males is appropriate under the right circumstances. These include, for example, hypersexuality with sexual deviance and psychological-treatment interfering sexual preoccupation. |
